By joining calls to share technology behind Covid-19 jabs, the Biden administration will add heft to a growing group of leaders who believe there is an urgent, if temporary, need for wider access to treatments if the world wants to end the pandemic.
South Africa and India have pushed for a TRIPS waiver to temporarily allow states to produce Covid-19 technologies without fear of IP infringement. But it faces pressure from rich countries, who want to protect their pharmaceutical industries.